J8655 HCPCS Level II code: Netupitant 300 mg and palonosetron 0.5 mg, oral

J8655 is the HCPCS code for “Netupitant 300 mg and palonosetron 0.5 mg, oral” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J8655

Netupitant 300 mg and palonosetron 0.5 mg, oral

Short description: Oral netupitant, palonosetro

HCPCS · United States

Notes for J8655

As CMS prints them, with any note J8655 takes from the headings above it.

Note

  • CMS processing note 0204: NCD 110.18.

Medicare details

The indicators CMS publishes with J8655 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Medical care
BETOS category
Other drugs
Added
Jan 1, 2016

Where J8655 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J8655Netupitant 300 mg and palonosetron 0.5 mg, oral

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J8655 mean?

J8655 is the HCPCS code for “Netupitant 300 mg and palonosetron 0.5 mg, oral” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J8655?

CMS lists J8655’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.